Revance Therapeutics (RVNC) Fails to deliver data

Key failure to deliver metrics for Revance Therapeutics:

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: £7.42 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Revance Therapeutics (RVNC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Revance Therapeutics (RVNC) - since 2014

Revance Therapeutics (RVNC) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	£35.31 M	£0.12 B	🇺🇸 USA
Biogen BIIB	£3.43 M	£74.8 M	🇺🇸 USA
MediciNova MNOV	£1.22 M	£1.25 M	🇺🇸 USA